https://charts.traderzeitung.de/phases/US42238H1086
string(1431) "{"isin":"US42238H1086","name":"HeartBeam Inc","stock_id_xnas":22560352,"stock_id_xnys":null,"generated_at":"2026-09-24 01:32:00","days":[{"date":"2026-09-21","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":null,"close_at":null,"complete":true,"perf_pct":null},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":0.428,"close_at":"2026-09-21 21:24:00","complete":true,"perf_pct":null},{"phase":3,"label":"post","from":"22:00","to":"26:00","close":null,"close_at":null,"complete":true,"perf_pct":null}]},{"date":"2026-09-22","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":null,"close_at":null,"complete":true,"perf_pct":null},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":0.43,"close_at":"2026-09-22 21:50:00","complete":true,"perf_pct":0.4673},{"phase":3,"label":"post","from":"22:00","to":"26:00","close":null,"close_at":null,"complete":true,"perf_pct":null}]},{"date":"2026-09-23","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":0.428,"close_at":"2026-09-23 15:13:00","complete":true,"perf_pct":-0.4651},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":0.39,"close_at":"2026-09-23 21:14:00","complete":true,"perf_pct":-8.8785},{"phase":3,"label":"post","from":"22:00","to":"26:00","close":0.395,"close_at":"2026-09-24 00:50:00","complete":false,"perf_pct":1.2821}]}]}"
HeartBeam

HeartBeam Aktie News & Nachrichten

[WKN: A3C7MX | Symbol: BEAT]
Realtimekurs
   
HeartBeam Inc is a medical technology company focused on developing higher resolution ambulatory electrocardiogram (ECG) solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The company's proprietary and patented technology platform captures the heart's electrical activity from three dimensions and synthesizes a 12-lead ECG from these signals. The company has received U.S. Food and Drug Administration (FDA) clearance for its ECG solutions.
Vorbörsliche Indikationen
Regulärer Handel
Nachbörslicher Handel

Artikel aus der Redaktion der Trader-Zeitung

Es konnten keine Nachrichten über HeartBeam gefunden werden.

MT Newswires 14.07.2026 13:35 Uhr

HeartBeam sagt, US-Patent erweitert die Fähigkeiten eines tragbaren EKG-Geräts

07:34 AM EDT, 07/14/2026 (MT Newswires) -- HeartBeam (BEAT) teilte am Dienstag mit, es habe ein neues US-Patent erhalten, das die akustische Sensorik

MT Newswires 30.06.2026 15:13 Uhr

HeartBeam schließt Patientenrekrutierung in Pilotstudie zur Herzinfarktdetektion ab

09:12 AM EDT, 06/30/2026 (MT Newswires) -- HeartBeam (BEAT) schloss die Patientenrekrutierung in der ALIGN-ACS-Pilotstudie zur Evaluierung des HeartBe

MT Newswires 25.06.2026 12:33 Uhr

HeartBeam CEO Robert Eno tritt zurück; Gründer Branislav Vajdic übernimmt die operative Leitung

06:32 AM EDT, 06/25/2026 (MT Newswires) -- HeartBeam (BEAT) teilte mit, dass Chief Executive Officer Robert Eno als CEO, Vorstandsmitglied und Hauptge